T he high-mobility-group protein family (HMG) I(Y) is a group of nonhistone chromosomal proteins.
1,2 HMG I(Y) binds to A⅐T-rich regions of DNA with A⅐T hooks, 3 inducing DNA conformational changes. HMG I(Y) can also regulate the affinity of some transcriptional factors to their DNAbinding elements while interacting with other transcriptional regulators. [4] [5] [6] [7] As a architectural protein regulator, HMG I(Y) can either facilitate the binding of some factors to their DNA-binding elements and increase promoter activity or interfere with the binding of some other factors and inhibit promoter activity. 8 -15 The affinity of HMG I(Y) binding to DNA depends on the structure of the DNA binding site. 4, 16, 17 Nuclear factor (NF)-B is among those factors considered to interact with HMG I(Y). 8 The inducible cyclooxygenase, cyclooxygenase-2 (COX-2), is considered a rate-limiting enzyme in the synthesis of the prostaglandins from arachidonic acid. 18 COX-2 can be induced rapidly by many physical and chemical stimuli in human endothelial cells, including shear stress, cobalt, mitogenic agents, and cytokines. 19 -21 The COX-2 gene has been cloned, and there are several potential response elements upstream from the transcription start site of the COX-2 gene, including Sp1, activator protein-2, NF-B, NF-IL6, cAMP response element, E box, and TATA. 22, 23 In addition, IL-1␤ regulates the translation of COX-2 gene by binding the 3Ј untranslated region and stabilizing mRNA. 24 The NF-IL6 site is responsible for induction of COX-2 by lipopolysaccharides and phorbol ester in vascular endothelial cells. 22 A cAMP response element mediates the effect of v-src on COX-2 expression in fibroblasts. 25 In a previous study, we showed that hypoxia induced the expression of COX-2 gene via NF-B p65 factor in human endothelial cells, demonstrating that hypoxia increases the binding of NF-B p65 to the relatively 3Ј consensus element in the upstream promoter of the COX-2 gene. 16 We found that the binding of the NF-B is a necessary, if not sufficient, step for the response of COX-2 to hypoxia. This finding left us with questions as to what other factors could be conveying hypoxia-specific signals to the nucleus, making the p65 interaction with the COX-2 promoter a sufficient stimulus for transactivation.
We hypothesized that the increase in COX-2 gene expression by NF-B in hypoxia was sensitive to interaction between NF-B or TATA elements and the HMG I(Y) family of proteins given this background information. We examined the expression of HMG I(Y) gene under hypoxic conditions and found evidence indicating that HMG I(Y) plays a role in the induction of COX-2 expression in hypoxia.
Materials and Methods

Cell Culture and Hypoxia Treatment
Human umbilical vein endothelial cells (HUVECs) (Clonetics) were cultured in medium 199 with 2.2 g NaHCO 3 /L (Life Technology, Inc), 5% FBS (Hyclone Laboratories), 50 g/mL endothelial cell growth supplement (Collaborative Biomedical Products), 50 g/mL heparin, and 1.0 g/mL hydrocortisone. HUVECs were studied within Յ5 passages from primary culture. HUVECs were exposed to ambient oxygen concentration of 1% (hypoxia) and 21% (normoxia) when the cells were grown to Ϸ60% to 80% confluence. The medium was preequilibrated to the environmental gas conditions overnight before cellular exposure. The possibility of generating reoxygenation artifacts after removal of the cells from the incubator was carefully prevented by immediately placing cells on ice and replacing hypoxic medium with lysis buffer.
Construction of Plasmids
The full-length human HMG I cDNA (pBS-HMG-I) was a gift from Dr Raymond Reeves. A set of deletion constructions of the COX-2 promoter, extending from Ϫ1800, Ϫ304, Ϫ245, and Ϫ45 bp upstream from the transcription start site to ϩ65, were produced with polymerase chain reaction. These deletions were inserted into vector pGL2-basic (Promega) containing a luciferase reporter gene and are referred to as pD4, pD3, pD2, and pD1, respectively. An HMG I(Y) expression plasmid pD3-HMG was driven by the COX-2 promoter through replacement of luciferase reporter gene (HindIII-EcoRV fragment) of pD3 with the HMG I cDNA insert of pBS-HMG-I. The pSV40-HMG(ϩ) and pSV40-HMG(Ϫ) plasmids were generated by removing the luciferase reporter gene in pGL-2 promoter (Promega) through restriction endonuclease digestion with EcoRV and HindIII and subsequently ligating HMG I cDNA in sense (ϩ) or antisense (Ϫ) orientation with the SV40-driven remnant of pGL-2. The correctness of the recombinant plasmids was confirmed by restriction digest analyses.
Western Blotting
Cell culture dishes were briefly washed with prechilled PBS before adding cell lysis buffer (50 mmol/L HEPES [pH 7.4], 10 mmol/L KCl, 1 mmol/L EDTA, 1 mmol/L EGTA, 1 mmol/L DDT, 0.5 mmol/L phenylmethylsulfonyl fluoride, 1 g/mL pepstatin A, 1 g/mL leupeptin, 10 g/mL trypsin inhibitor, 10 g/mL aprotinin, and 0.5% Triton). Protein concentration was measured using BioRad protein assay reagent. After electrophoresis in 12% SDS-PAGE gel, the 30 g cell lysate was blotted to a nitrocellulose membrane. Nonspecific binding was blocked by soaking the membrane in a TBST buffer (20 mmol/L Tris base [pH 7.5], 137 mmol/L NaCl, and 0.1% Tween 20) containing 5% nonfat milk for 30 minutes at 37°C. The membrane was then incubated with polyclonal IgG to NF-B p65 (1:1500 dilution), the inhibitory protein that binds NF-B p65 precursors (IB, 1:1000 dilution), or HMG I(Y) (1:1000 dilution) (Santa Cruz Biotechnology) for 30 minutes at 37°C and washed in TBST for 5 minutes (5 times each). After a similar incubation with horseradish peroxidase-conjugated anti-IgG, the membrane was washed and incubated in luminol ECL detection reagents (Amersham) and exposed to the film. Incubation with IgG monoclonal antibody to chicken ␣-tubulin (Sigma) at 1:2500 dilution was also performed for comparative purposes.
Electrophoretic Mobility Shift Assay
Nuclear protein extraction and gel shift assays were performed as previously described for NF-B-3Ј. 16 The duration of HUVEC exposure to hypoxia was 2 hours. The binding reaction was performed with end-labeled oligonucleotide from the COX-2 promoter and 2 to 6 g of nuclear extract. The sense strand of the doublestranded TATA box oligo used for electrophoretic mobility shift assay (EMSA) was also taken from the COX-2 promoter region: 5Ј-TTGGTTTTCAGTCTTATAAAAAGG-3Ј.
Transfection for Reporter Gene Assay
We performed transfection analysis using luciferase reporter gene constructions in HUVECs, which were grown in 35-mm 6-well plates to 70% to 80% confluence. For each well, 12 L of lipofectin reagent (GIBCO BRL) was added into 88 L of Opti-MEM-1 medium (Life Technologies, Inc) and incubated at room temperature for 45 minutes. Then 2.0 g of pD1-pD4 and 0.5 g of pSV2PAP, containing the alkaline phosphatase reporter gene downstream from an SV40 promoter, were added into 100 L Opti-MEM-1 medium. The lipofectin and DNA solution were mixed and incubated at room temperature for 15 minutes, and then another 800 L of Opti-MEM-1 medium was added to the mixture. After the HUVECs were rinsed once with the Opti-MEM-1 medium, the lipofectin and DNA mixture was overlaid on the cells and incubated at 37°C for 8 hours. We then replaced the mixture with the original medium and let the cells recover overnight. HUVEC cells were exposed to hypoxia or further normoxia for 24 hours before reporter gene assay. An additional 0.5 to 4.0 g of HMG I expression plasmid (as indicated in Figure 5 ) was added into the DNA mixture. A control plasmid containing only the COX-2 promoter but no reporter gene was used to make the DNA quantity constant. Luciferase activity was determined in cell lysates through single photon counting on a microplate scintillation counter. Alkaline phosphatase activity was determined as previously described to control transfection efficiency. 16 The values for luciferase (counts per second) and alkaline phosphatase (optical density) were reported as a ratio, thereby correcting for discrepancies in transfection efficiency.
Northern Blotting
Total RNA was extracted from HUVECs treated with normoxia and hypoxia with the use of RNAzol B (TEL-TEST, Inc). Total RNA (20 g/well) was loaded in a 1.2% formaldehyde agarose gel. After electrophoresis, the nucleic acids were transferred to a nylon membrane by blotting. A SacI fragment of HMG I cDNA (1186 bp) was randomly labeled with 32 P as a probe. Randomly labeled 18S RNA was also used for comparative purposes.
Nuclear Runoff Assay for COX-2 Transcripts
Nuclei were harvested from HUVECs as follows: cells were rinsed twice with ice-cold PBS, and then 5 to 8ϫ10 7 cells were scraped into a 50-mL tube with 4 mL of ice-cold PBS, centrifuged for 5 minutes at 500g and 4°C, loosened by vortexing gently, and then lysed with 4 mL of NP-40 lysis buffer (10 mmol/L Tris-HCl [pH 7.5], 1.5 mmol/L MgCl 2 , 140 mmol/L NaCl, and 1% NP-40). We incubated lysed cells for Ϸ3 to 5 minutes on ice, checked the cell lysate with a phase-contrast microscope, and then centrifuged the nuclei at 500g at 4°C for 5 minutes. The nuclei were washed twice in 1 mL of 20 mmol/L Tris-HCl (pH 8.0), 20% glycerol, 140 mmol/L KCl, 10 mmol/L MgCl 2 , 1 mmol/L MnCl 2 , and 14 mmol/L ␤-mercaptoethanol. After centrifugation at 650g for 4 minutes, we resuspended the nuclei in 200 L of this buffer and stored them in liquid nitrogen. Frozen nuclei were thawed to 25°C, and nascent transcripts were labeled with 20 L of 10 mCi/mL [␣-
32 P]UTP(800 Ci/mmol) and 2.5 L of 100 mmol/L ATP, CTP, and GTP for 30 minutes at 30°C. RNA was extracted from the nuclei by adding 0.9 mL RNazol B and 0.12 mL chloroform. The aqueous content was separated, and RNA was precipitated with isopropanol and washed with 70% ethanol. The RNA was resuspended in 100 L Tris-EDTA solution and 1 L of RNase inhibitor. Limited alkaline hydrolysis was achieved with the addition of 20 L of 1 mol/L NaOH and incubation on ice for 10 minutes, followed by neutralization with 40 L of 1 mol/L HEPES at pH 7.9. RNA was precipitated with sodium acetate and ethanol. RNA was hybridized to nitrocellulose to which DNA for COX-1 and COX-2, along with a negative control, had been slot-blotted. The radiolabeled RNA transcripts that hybridized to the membrane were identified by exposure to film for 4 days.
GST-HMG Fusion Protein
The full-length HMG I(Y) cDNA coding region was inserted into the glutathione-S-transferase (GST) fusion protein expression vector pGEX-4T-1 by ligation to EcoRI and SmaI restriction sites. Escherichia coli BL21, transformed with the recombinant plasmid, was grown in LB medium supplemented with 100 g/mL ampicillin at 37°C overnight. The cells were then diluted 1:10 in fresh LB and grown for another hour. Expression of the GST-HMG fusion protein was induced by incubation with 1.0 mmol/L isopropyl-␤-Dthiogalactoside for 4 hours. The cells were then resuspended in PBS and lysed by sonication. The proteins were brought into solution with 1% Triton X-100. A crude extract was separated by centrifugation and added to a 50% slurry of glutathione Sepharose 4B equilibrated with PBS. After gentle agitation at room temperature for 30 minutes, the matrix was sedimented and washed with PBS. Then GST-HMG was eluted by 10 mmol/L reduced glutathione, and the fusion protein was analyzed by SDS-PAGE.
Radioimmunoassay of PGE 2
HUVEC cells were grown to 70% to 80% confluence and exposed to 2 hours, 6 to 10 hours, 24 hours, and 48 hours of normoxic or hypoxic conditions. Immediately after stimulation, the culture medium was collected into prechilled polypropylene tubes coated with a solution of 4.5 mmol/L EDTA combined with 10 g/mL indomethacin to inhibit further prostaglandin synthesis. Prostaglandin E 2 (PGE 2 ) levels were determined using a commercially available 125 I radioimmunoassay kit (Dupont). PGE 2 levels were assayed directly from medium as follows: 100 L sample, 100 L rabbit anti-serum, and 100 L tracer (iodinated analogue of PGE 2 ) were incubated together overnight at 4°C. Then 1 mL cold precipitating reagent (16% PEG 6000 and 0.05% sodium azide in 50 mmol/L phosphate buffer, pH 6.8) was added to precipitate the antibody-bound tracer. After centrifugation, the pellet containing the antibody-antigen complex was counted in a gamma counter. Results from a serial dilution of standard concentrate were used to construct standard (dose-response) curves from which the unknowns were read by interpolation. The value in the medium at time zero was subtracted from each value to yield an index of cellular prostanoid production above that baseline over time. Protein concentration in each cell culture dish was measured after 2 washings with PBS. NaOH (0.62 mol/L) was added to solubilize the protein. The protein concentrations from each dish were then measured with a modified Bradford method (Bio-Rad) using BSA as a standard. 26 The results of PGE 2 measurements were reported as picograms per milligram of protein.
Results
Search for Hypoxia-Related Regulatory Elements in COX-2 Promoter
Hypoxia is known to regulate transcription via multiple factors. For instance, hypoxia-inducible factor 1 (HIF-1), which mediates erythropoietin induction in hypoxia, also regulates the transcription of genes encoding glycolytic enzymes. The presence of a HIF-1 binding site is necessary but not sufficient to direct the hypoxia-induced transcription of these genes. 27 There are several potential cis-acting elements within the 350 bases upstream from the COX-2 transcription start site ( Figure 1A ). The known hypoxiainducible element 1 (HIE-1), which binds HIF-1, has not been found upstream or downstream from the COX-2 coding region. We performed several transfections with a set of deletions of the COX-2 promoter to search for a hypoxia regulatory element ( Figure 1B) . The D4 region is the intact COX-2 promoter. It displayed full COX-2 promoter activity and a full reporter gene response to hypoxia induction when transfected in a vector. Transfection using pD3, which features 1496 bp less of the COX-2 upstream promoter than does D4, showed no significant decrease of the promoter activity. The smallest construct, pD1, containing the basal promoter of COX-2 and a TATA box, displayed a minimal response to hypoxia. Although insignificant in itself, this minimal response suggested to us that hypoxia may induce the COX-2 gene through not only the NF-B binding site but also the TATA box and other DNA-protein binding sites.
Mechanism of NF-B Activation by Hypoxia
Previous work from our laboratory indicated that hypoxia activates the binding of NF-B p65 to a consensus NF-B oligonucleotide. We noticed that the NF-B 5Ј-binding site in the COX-2 promoter, which is Ϫ440 bp upstream from the transcription start site, did not have any contribution to the COX-2 promoter activity but did constitutively bind with normoxic and hypoxic HUVEC nuclear protein extracts. By comparison, hypoxia enhances protein binding to the NF-B-3Ј binding site in the COX-2 promoter. We examined IB-␣ and NF-B p65 by Western blot in HUVEC cell lysates (Figure 2 ). ␣-Tubulin was used as an equivalent loading control. The protein level of both factors did not change between normoxia and hypoxia (from 30 minutes to 24 hours). This suggests that the activation of NF-B by hypoxia is regulated by posttranslational modification and/or binding factors such as IB-␣ in HUVECs. We reasoned that other factors like HMG I(Y) may play a role in the hypoxia-specific binding of NF-B transactivation factors to certain NF-B elements. This hypoxia-specific interaction might occur through cooperative binding of HMG I(Y) to the A⅐T region, facilitating binding of NF-B p65 to the NF-B-3Ј element.
Hypoxia, HMG I(Y), and Nuclear Protein Binding to NF-B-3 and TATA
Hypoxic nuclear protein caused our radiolabeled NF-B-3Ј oligonucleotide probe to shift electrophoretically. The combination of nuclear protein from hypoxic cells and the GST-HMG fusion protein produced a synergistically enhanced shift, as seen in Figure 3 . The range of GST-HMG protein used in a series of EMSA experiments revealed a maximal shift at 1 to 3 ng with a definite decrease in NF-B-3Ј shift above this amount. We also recorded that a GST protein without HMG had no effect on electrophoretic mobility. When hypoxic nuclear protein was used in this experiment, the shift intensified and was observed at lower doses of GST-HMG. When a TATA oligo was used for EMSA (Figure 4) , multiple bands were shifted, corresponding to the shift of HMG I(Y) and TATA-binding protein (TBP) recorded in a previous study of TATA DNA-protein interactions. 12 Hypoxia induced increased shifting, as did HMG I(Y), suggesting a functional correlation between hypoxic induction of transcription and DNA binding with HMG I(Y) proteins at the TATA box as well as at the NF-B-3Ј element of the COX-2 promoter. However, we cannot conclude that this DNA-protein interaction is of functional significance given the limitations of EMSA; therefore, further experiments were performed to examine the effect of HMG I(Y) proteins on COX-2 promoter function and gene expression.
Upregulation of COX-2 Promoter Activity by HMG I(Y)
To understand how HMG I(Y) regulates the expression of the COX-2 gene under hypoxia, we constructed an HMG I expression plasmid by replacing the luciferase gene with HMG I cDNA in the COX-2 promoter construct pD3, making pD3-HMG, in which the expression of the HMG I gene was driven by the COX-2 promoter. COX-2 promoter constructs ligated to luciferase reporters or HMG I were used to cotransfect the HUVECs. Expression of HMG I(Y) remarkably increased the COX-2 promoter activity in a dose-dependent manner under hypoxia ( Figure 5A ). Since HMG I(Y) itself is upregulated by hypoxia, as described later, the synergistic effect of HMG I(Y) and hypoxia greatly increased the expression of reporter gene compared with baseline. This stimulation is conspicuous and as strong as that of phorbol ester and lipopolysaccharide 22 or 20% FCS. 20 pD1 contains the basal promoter of the COX-2 gene. We found that increased HMG I(Y) could also upregulate the basal promoter activity of COX-2 in cotransfected HUVECs under hypoxia ( Figure 5B ). This effect was not dependent on the linkage between hypoxia-sensitive elements in the COX-2 promoter and HMG I(Y) expression, as modeled with the pD3-HMG vector. Repeating these experiments with a constitutively active expression vector, pSV40-HMG(ϩ), demonstrated that a sufficient amount of HMG I(Y) could stimulate reporter gene expression by the COX-2 promoter as much as hypoxia could ( Figure 5C ).
Transcription of COX-2 in Hypoxia
Hypoxia had been previously shown to regulate the transcription of COX-2 via the NF-B p65 transactivation protein. We confirmed this finding using a nuclear runoff assay by hybridization of radiolabeled nascent transcripts to immobilized pBS-hgCOX-2-3Ј, containing the 3Ј end (bases 4490 to 10488) of the human genomic COX-2 sequence. 28 The positive control was demonstrated by hybridization to pBS-hCOX-1, containing a 1750-bp insert 4 cpm NF-B-3Ј oligonucleotide as a probe. Nuclear protein of HUVECs treated with continued normoxia or 2 hours of hypoxia was assayed: 2.7 g was used in lanes 1 to 9, 4.0 g was used in lanes 11 to 13, and 2.5 g was used in lanes 14 to 16. Lanes 1 to 4 demonstrate the synergy between hypoxic nuclear protein and GST-HMG fusion protein in shifting the NF-B-3Ј probe. NF-B-3Ј was maximally shifted in normoxic nuclear protein (N) experiments by 3.0 ng GST-HMG fusion protein (range, 0.3 to 30.0 ng in lanes 5 to 8). When hypoxic nuclear protein was added to NF-B-3Ј probe and GST-HMG (0.3 to 30 ng in lanes 14 to 16), more shifting occurred with less GST-HMG. A 100-fold excess of cold NF-B-3Ј oligo was added to block specific binding in lane 9. BSA (5 g) was added to lane 10 instead of nuclear protein. Lanes 11 to 13 demonstrate that GST protein (without the HMG fusion) has no effect on DNA-protein binding. S indicates specific shift bands; NS, nonspecific shift band. of COX-1 cDNA 29 ; the negative control was obtained using cDNA for pBluescript II SK(ϩ). Figure 6 illustrates the comparison between COX-1 and COX-2 transcripts obtained from nuclei from HUVECs that had been treated for 30 minutes, 2 hours, and 4 hours of hypoxia versus normoxia. Although transcription of the COX-1 gene did not change during hypoxia, transcription of the COX-2 gene was increased by hypoxia.
Regulation of HMG I(Y) Gene Expression by Hypoxia in HUVECs
We investigated how hypoxia regulated the HMG I(Y) gene expression in HUVECs. Data are shown in Figure 7 . We found that steady-state levels of HMG I(Y) mRNA were nearly doubled by hypoxia by 2 hours (Figure 7A ). The peak prevalence of HMG I(Y) mRNA was reached between 2 and 6 hours with the hypoxia treatment and subsequently tailed off. The change in mRNA was relatively small compared with the Ͼ5-fold in increase HMG I(Y) protein caused by hypoxia ( Figure 7B ). We observed that protein prevalence also began to decrease after 6 hours of hypoxia.
Effects of Sense and Antisense HMG I(Y) on COX-2 Gene Expression
We expressed sense and antisense HMG I(Y) RNA by transfecting HUVECs with constitutively active vectors [pSV40-HMG(ϩ) and pSV40-HMG(Ϫ), respectively]. The effect of pSV40-HMG(ϩ) on hypoxia-mediated increases in COX-2 immunoreactive protein are illustrated in Figure 8 . All cells were exposed to equal amounts of DNA through balance transfection with empty vectors. This was important, since we found that transfected cells produced less COX-2 than did cells that had not been transfected with a given amount of DNA. We found that overexpression of HMG proteins led to progressive increases in COX-2 due to hypoxia. Since there was virtually no COX-2 produced at baseline, we could not decrease COX-2 by antisense overexpression in our model. However, using relative reporter gene activity as an index as illustrated in Figure 9 , we documented that pSV40-HMG(Ϫ) inhibited and pSV40-HMG(ϩ) stimulated luciferase reporter gene activity linked to the COX-2 promoter. These experiments indicate a specific role for HMG I(Y) proteins in the regulation of COX-2 gene expression by hypoxia.
Endothelial PGE 2 in Hypoxia
The radioimmunoassay for PGE was performed on HUVEC media directly after 2 hours, 10 hours, 24 hours, and 48 hours of hypoxic or normoxic stimulation. Direct assay of cell culture medium for immunoactive PGE 2 levels has been reported previously. 30 Assays on the normoxic cells were performed as controls for basal synthesis of PGE 2 . Parallel hypoxic cells at each point were also pretreated with 4 g/mL indomethacin to block the cyclooxygenase activity. As shown in Figure 10 , the PGE 2 level was not changed after 2 hours of hypoxic stimulation but was slightly increased by hypoxia after 10 hours and 24 hours. PGE 2 was significantly increased after 48 hours of hypoxia compared with normoxia. Furthermore, pretreatment of cells with indomethacin eliminated the hypoxia-induced enhancement of the PGE 2 synthesis. The time course of the PGE 2 response also corresponds to that of COX-2 protein induction by hypoxia, 16 suggesting that the enhancement of the PGE 2 synthesis by hypoxia is dependent on increased COX-2 protein.
Discussion
The present study reveals for the first time that HMG I(Y) is upregulated by hypoxia in HUVECs. The time course of the Figure 5 . Reporter gene assays using deletion constructs demonstrate that HMG I(Y) upregulates the expression of COX-2 under hypoxic conditions. HUVECs were cotransfected with either 2 g of pD3, a luciferase reporter that demonstrates full COX-2 promoter activity in hypoxia (A and C), or pD1, a similar luciferase reporter ligated to a basal COX-2 promoter (B), and either 0.5 to 4 g of pD3-HMG expression plasmid (A and B) or the constitutively active pSV-HMG(ϩ) overexpression vector in the sense orientation (C). The nonexpressing plasmid pBS-HMG was used to control DNA concentration so that the total for all conditions was equal. Also, 0.5 g of the alkaline phosphatase plasmid pSV2PAP was used in each experiment for correcting the efficiency of transfection. Four to six independent transfections were performed for each dose. Cell lysates were harvested 24 hours after treatment with hypoxia and assayed for luciferase activity and alkaline phosphatase activity. Data were expressed as meanϮSEM of LUC/PAP ratios.
response indicates that HMG I(Y) upregulation is an early event. The data herein suggest that HMG I(Y) proteins are constituents of an enhanceosome that regulates hypoxiamediated transcription of COX-2 in a manner analogous to the synergistic roles of HMG I(Y) and NF-B protein factors in induction of the human interferon-␤ gene. 14, 31 The specific role of the HMG I(Y) protein family is indicated by direct effects of this protein on DNA-protein interactions and COX-2 gene expression, along with the ability of antisense RNA of HMG I(Y) to decrease COX-2 promoter activity.
The cyclooxygenases catalyze the rate-limiting step in the synthesis of prostaglandins from arachidonic acid. Since the time course of the PGE 2 response to hypoxia in our experiments corresponds with that of COX-2 protein in hypoxia 16 and the change in PGE 2 is inhibited by the cyclooxygenase inhibitor indomethacin, we propose that hypoxia increases the PGE 2 level in human vascular endothelial cells via inducible COX-2 synthesis. Other studies have shown that the transcription of the HMG I(Y) gene is inducible in human lymphoid cells by phorbol esters and calcium ionophore stimulation. 2 However, the time course of the HUVEC HMG I(Y) response to hypoxia is shorter than that in response to phorbol ester in lymphoid tissue. HMG I(Y) has been linked Figure 6 . Nuclear runoff of nascent RNA transcripts reveals increased transcription of the COX-2 gene in hypoxia. Radiolabeled RNA from nuclei obtained from HUVECs that had been exposed to normoxia or hypoxia was hybridized to immobilized pBS-hgCOX-2-3Ј, containing the 3Ј end (bases 4490 to 10488) of the human genomic COX-2 sequence. 28 The positive control was demonstrated by hybridization to pBS-hCOX-1, containing a 1750-bp insert of COX-1 cDNA. 29 COX-2 transcription was demonstrably increased during hypoxia; no effect was seen on the positive control COX-1. The negative control pBluescript II SK(ϩ) is not shown. to carcinogenesis in pulmonary hamartomas 32 and uterine leiomyomata. 33 We speculate, on the basis of our data, that HMG I(Y), COX-2, and PGE 2 are part of a proliferative, proinflammatory, and angiogenic response to hypoxia in cardiovascular diseases.
COX-2 mRNA metabolism has been linked to the "AUUUA" motif in its 3Ј untranslated region. 23 There does not appear to be such a motif in the HMG I(Y) 3Ј untranslated region.
1 Therefore, another negative-feedback mechanism may be responsible for the reduction of HMG I(Y) RNA in High-level expression of HMG I(Y) is also found during embryonic development. 36 Previous studies demonstrate that HMG I(Y) stimulates the binding of Sp1, NF-B, and activating transcription factor-2 to DNA and that it can interact with TBP. 5, 9, 10, 31 We propose that HMG I(Y) mediates the induction of COX-2 by hypoxia on 3 levels: (1) HMG I(Y) may bind to the TATA box and interact with TBP, altering basal promoter activity; (2) HMG I(Y) may facilitate Sp1, NF-B, and activating transcription factor-2 binding to DNA as a cofactor, increasing COX-2 enhanceosome function at the promoter; and (3) binding of HMG I(Y) to A⅐T-rich elements may change the conformation of DNA itself, focally altering the helical structure of DNA and thereby acting as a facilitator (or, when in excess, an inhibitor) of enhanceosome-mediated transcription.
HMG I(Y) is a unique multifunctional regulator because it interacts with both DNA and many other factors. HMG I(Y) is known to cooperate with NF-B and compete with NF-AT factors in binding to DNA.
11 HMG I(Y) can directly recognize and alter the structure of localized regions of chromatin, 17, 35 thereby facilitating, inhibiting, or replacing the binding of some factors. 9, 11, 12, 37, 38 The interaction between HMG I(Y) and NF-B p65 in the induction of COX-2 transcription by hypoxia provides new insight into the mechanisms of promoter-specific transcriptional regulation and cell-specific gene expression. Our data do not point to a one-protein/oneenhancer mechanism of transcription. In the case of COX-2, the enhanceosome model provides a template for our proposal that hypoxia-mediated transcription in vascular endothelium occurs when a specific combination of protein factors binds to specified sites within a promoter region. Figure 10 . HUVEC production of PGE 2 is increased during hypoxia by a cyclooxygenase-dependent mechanism. Cells were incubated for 2 hours, 10 hours, 24 hours, and 48 hours under normoxic or hypoxic conditions. Some hypoxic cells were also pretreated with 4 g/mL indomethacin to block the cyclooxygenase activity. PGE 2 levels were assayed by radioimmunoassay of culture medium. PGE 2 levels from normoxic cells are presented as a control. Results are expressed in picograms per milligram protein as the meanϮSEM (nϭ3). *PϽ0.05 compared with normoxia and hypoxiaϩindomethacin.
